Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis.
Maarten BakBea CampfortsPatrick DomenTherese van AmelsvoortMarjan DrukkerPublished in: Acta psychiatrica Scandinavica (2024)
The GLP-1 agonists exenatide and liraglutide are promising drugs for inducing weight loss in patients with AIWG. The adverse effects are acceptable, and the addition of GLP-1 does not increase the severity of psychopathology. However, more research is needed.